Cleared Traditional

K981330 - QUANTA LITE MPO IGG (MYELOPEROXIDASE) T...

K981330 is the FDA 510(k) clearance for QUANTA LITE MPO IGG (MYELOPEROXIDASE) T... by Inova Diagnostics, Inc.. It is a Class 2 Immunology device (product code MOB) cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K981330 · Inova Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
67d
Days
Class 2
Risk

K981330 is an FDA 510(k) clearance for the QUANTA LITE MPO IGG (MYELOPEROXIDASE) TEST KIT. Classified as Test System, Antineutrophil Cytoplasmic Antibodies (anca) (product code MOB), Class II - Special Controls.

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on June 19, 1998 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Inova Diagnostics, Inc. devices

Submission Details

510(k) Number K981330 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 1998
Decision Date June 19, 1998
Days to Decision 67 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 104d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)

All 35
Devices cleared under the same product code (MOB) and FDA review panel - the closest regulatory comparables to K981330.
BINDAZYME ANTI-PR3 ENZYME IMMUNOASSAY KIT
K981029 · The Binding Site, Ltd. · Jul 1998
BINDAZYME ANTI-MPO ENZYME IMMUNOASSAY KIT
K981030 · The Binding Site, Ltd. · Jul 1998
QUANTA LITE PR3 IGG (SERINE PROTEASE) TEST KIT
K981328 · Inova Diagnostics, Inc. · Jun 1998
IMMUNO CONCEPTS ANCA TEST SYSTEM
K974463 · Immuno Concepts, Inc. · Feb 1998
IMMUNO CONCEPTS ANCA TEST SYSTEMS
K974478 · Immuno Concepts, Inc. · Feb 1998
VIRGO ANCA SCREEN KIT
K973822 · Hemagen Diagnostics, Inc. · Nov 1997